Pregled bibliografske jedinice broj: 15117
Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation
Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation // Applied biochemistry and biotechnology, 69 (1998), 2; 99-111 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 15117 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation
Autori
Branović, Karmen ; Gebauer, Branka ; Treščec, Anđa ; Benko, Bojan
Izvornik
Applied biochemistry and biotechnology (0273-2289) 69
(1998), 2;
99-111
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
factor VIII; chromatography; cryoprecipitate
Sažetak
The trend toward the production of high purity factor VIII concentrates for clinical use is still in progress. Although all plasma derivatives must undergo viral inactivation procedures, the possibility of transmission of viral diseases is not completely eliminated. Ln order to reduce such risk, we have included double virus inactivation in the procedure of factor VIII concentrate production. Ln a scale-up procedure for isolation of factor VIII from cryoprecipitate, two methods were used. The first is based on the chromatographic purification of factor VIII after pasteurization of cryoprecipitate solution and solvent/detergent (S/D) inactivation of viruses. The second is based on multistep precipitation of factor VIII by sodium chloride and glycine. Viral inactivation was performed by combination of S/D treatment and heating of final freeze-dried product 30 min at 100 degrees C. The typical yield of factor VIII activity in the freeze-dried product was about 20% for the first method, and 25-30% for the second. Electrophoretic analyses of both factor VIII preparations by SDS-PAGE and IEF show very low content of contaminant proteins, in accordance with observed 400-650-fold increase of their specific activity over plasma. Both factor VIII products were stable in the liquid state for more than 24 h at room temperature. The final products, after double viral inactivation, are considered to be suitable for clinical evaluations.
Izvorni jezik
Engleski
Znanstvena područja
Kemija
POVEZANOST RADA
Ustanove:
Imunološki zavod d.d.,
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac
Profili:
Anđa Treščec
(autor)
Bojan Benko
(autor)
Karmen Branović-Čakanić
(autor)
Branka Gebauer
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE